Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains

Tuberculosis

Volumn 82, Issue 6, 2002, Pages 283-291

  Al Zarouni, Mansour ^a,b   Dale, Jeremy W ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b Al Qassimi Hospital   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; HEAT SHOCK PROTEIN 60; LIVE VACCINE;

ACYLATION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; ELECTROPORATION; GENE DELETION; GENE EXPRESSION; GENETIC STABILITY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REPORTER GENE;

EID: 0036958443     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2002.0374     Document Type: Article

References (40)

1. Dubos R J, Pierce C H. Differential characteristics in vitro and in vivo of several substrains of BCG I. Multiplication and survival in vitro. Am Rev Tuberc 1956; 74: 655-666.
2. Dubos R J, Pierce C H. Differential characteristics in vitro and in vivo of several substrains of BCG. II. Morphological characteristics in vitro and in vivo. Am Rev Tuberc 1956; 74: 667-682.
3. Dubos R J, Pierce C H. Differential characteristics in vitro and in vivo of several substrains of BCG. III. Multiplication and survival in vivo. Am Rev Tuberc 1956; 74: 683-698.
4. Dubos R J, Pierce C H. Differential characteristics in vitro and in vivo of several substrains of BCG. IV. Immunizing effectiveness. Am Rev Tuberc 1956; 74: 699-717.
5. Ladefoged A, Bunch-Christensen K, Guld J. The protective effect in bank voles of some strains of BCG. Bull World Health Organ 1970; 43: 71-90.
6. Bunch-Christensen K. Evaluation of BCG vaccines in children, the effect of strain and dose. J Biol Stand 1977; 5: 159-164.
7. Gheorghiu M, Lagrange P H. Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) 1983; 134C: 125-147
8. Osborn T W. Changes in BCG strains. Tubercle 1983; 64: 1-13.
9. Minnikin D E, Minnikin S M, Parlett J H, Goodfellow M, Magnusson M. Mycolic acid patterns of some species of Mycobacterium. Arch Microbiol 1984; 139: 225-231.
10. Milstien JB, Gibson JJ. Quality control of BCG vaccines by the World Health Organization: a review of factors that may influence vaccine effectiveness and safety. Geneva, World Health Organisation, 1989.
11. Mahairas G G, Sabo P J, Hickey M J, Singh D C, Stover C K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178: 1274-1282.
12. Collins D M, De Lisle G W. BCG identification by DNA restriction fragment patterns. J Gen Microbiol 1987; 133: 1431-1434.
13. Fomukong N G, Dale J W, Osborn T W, Grange J M. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol 1992; 72: 126-133.
14. Oettinger T, Jorgensen M, Ladefoged A, Haslov K, Andersen P. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuberc Lung Dis 1999; 79: 243-250.
15. Behr M A, Small P M. A historical and molecular phylogeny of BCG strains. Vaccine 1999; 17: 915-922.
16. Stover C K, de la Cruz V F, Fuerst T R et al. New use of BCG for recombinant vaccines. Nature 1991; 351: 456-460.
17. Baulard A, Kremer L, Supply P et al. A new series of mycobacterial expression vectors for the development of live recombinant vaccines. Gene 1996; 176: 149-154.
18. Lagranderie M, Winter N, Balazuc A M, Gicquel B, Gheorghiu M. A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes. AIDS Res Hum Retroviruses 1998; 14: 1625-1633.
19. Snewin V, Stewart G, Young D. Genetic strategies for vaccine development. In: Haffull GF, Jacobs WR, eds. Molecular genetics of mycobacteria. Washington, DC: ASM Press, 2000: pp 279-296.
20. Dellagostin O A, Esposito G, Eales L-J, Dale J W, McFadden J. Activity of mycobacterial promoters during intracellular and extracellular growth. Microbiology 1995; 141: 1785-1792.
21. DasGupta S K, Jain S, Kaushal D, Tyagi A K. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines. Biochem Biophys Res Commun 1998; 246: 797-804.
22. Kremer L, Baulard A, Estaquier J, Content J, Capron A, Locht C. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol 1995; 177: 642-653.
23. Robb C W, Ni H L, Wang H M, Barrett A D T, Niesel D W. Expression of an 18 kDa::PhoA fusion protein in Mycobacterium spp. J Microbiol Methods 1998; 33: 245-254.
24. Triccas J A, Britton W J, Gicquel B. Isolation of strong expression signals of Mycobacterium tuberculosis. Microbiology 2001; 147: 1253-1258.
25. Triccas J A, Berthet F X, Pelicic V, Gicquel B. Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells. Microbiology 1999; 145: 2923-2930.
26. Timm J, Gomez M, Smith I. Gene expression and regulation. In: Ratledge C, Dale JW, eds. Mycobacteria: molecular biology and virulence. Oxford: Blackwell Science, 1999: pp 59-92.
27. Chubb A J, Woodman Z L, Tatley F M P R D, Hoffmann H J, Scholle R R, Ehlers M R W. Identification of Mycobacterium tuberculosis signal sequences that direct the export of a leaderless β-lactamase gene product in Escherichia coli. Microbiology 1998; 144: 1619-1629.
28. Matsuo K, Yamaguchi R, Yamazaki A et al. Establishment of a foreign antigen secretion system in mycobacteria. Infect Immun 1990; 58: 4049-4054.
29. Thole J, Janssen R, Young D. Mycobacterial antigens. In: Ratledge C, Dale JW, eds. Mycobacteria: molecular biology and virulence. Oxford: Blackwell Science, 1999: pp 356-370.
30. Buddle B M, Wards B J, Aldwell F E, Collins D M, De Lisle G W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002; 20: 1126-1133.
31. Haeseleer F. Structural instability of recombinant plasmids in mycobacteria. Res Microbiol 1994; 145: 683-687.
32. Kumar D, Srivastava B S, Srivastava R. Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli β-galactosidase in Mycobacterium smegmatis and its implication in vaccine development. Vaccine 1998; 16: 1212-1215.
33. da Cruz F W, McBride A J A, Conceicao F R, Dale J W, McFadden J, Dellagostin O A. Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine 2001; 20: 731-736.
34. Cole S T, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544.
35. Cole S T, Eiglmeier K, Parkhill J et al. Massive gene decay in the leprosy bacillus. Nature 2001; 409 (6823): 1007-1011.
36. Medeiros M A, Dellagostin O A, Armoa G R et al. Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics. Microbiology 2002; 148: 1999-2009.
37. Al-Zarouni M. Expression of recombinant antigen in BCG 2000. Ph.D. Thesis, University of Surrey.
38. O'Callaghan C H, Morris A, Kirby S M, Shingler A H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283-288.
39. Gomez M, Smith I. Determinants of mycobacterial gene expression. In: Hatfull GF, Jacobs Jr Weds. Molecular genetics of mycobacteria. Washington: ASM Press, 2000: pp. 111-129.
40. Picardeau M, Le Dantec C, Vincent V. Analysis of the internal replication region of a mycobacterial linear plasmid. Microbiology 2000; 146: 305-313.